overall survival

Survival adjusting for crossover: phase 3 study of ibrutinib vs chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma
Steven Coutre, Alessandra Tedeschi, Tadeusz Robak, Paul M. Barr, Carolyn Owen, Osnat Bairey, Jan Burger, Cathy Zhou, Lori Styles, Danelle F. James, Thomas J. Kipps

Haematologica Jan 2018, haematol.2017.175380; DOI: 10.3324/haematol.2017.175380
The impact of anemia on overall survival in patients with myelofibrosis treated with ruxolitinib in the COMFORT studies
Vikas Gupta, Claire Harrison, Elizabeth O. Hexner, Haifa Kathrin Al-Ali, Lynda Foltz, Michael Montgomery, William Sun, Prashanth Gopalakrishna, Hagop Kantarjian, Srdan Verstovsek

Haematologica Dec 2016, 101 (12) e482-e484; DOI: 10.3324/haematol.2016.151449
CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia
Eva Barragán, María Carmen Chillón, Remedios Castelló-Cros, Nerea Marcotegui, María Isabel Prieto, Montserrat Hoyos, Raffaella Pippa, Marta Llop, Amaia Etxabe, José Cervera, Gabriela Rodríguez, Ismael Buño, José Rifón, Jorge Sierra, Marcos González, María J. Calasanz, Miguel A. Sanz, María D. Odero

Haematologica May 2015, 100 (5) e183-e185; DOI: 10.3324/haematol.2014.118117